首页> 中文期刊> 《中国医药科学》 >TCT检测及巴氏涂片细胞学检测在宫颈癌检查中结果对比分析

TCT检测及巴氏涂片细胞学检测在宫颈癌检查中结果对比分析

         

摘要

Objective To investigate clinical value of TCT testing and Pap cytology in cervical cancer screening. Methods The women were regarded as research object, who accepted cervical cancer checks in our hospital women’s health clinic from March 2012 to March 2014. 22500 cases(group A) were tested by Pap smear cytology,and 14000 cases(group B) were tested by liquid-based cytology. Cytology positive was then tested by colposcopic biopsy. The detection results of both methods were then compared and analyzed. Results Cell screening positive rate of group A was 5.46%(1228/22500), and positive coincidence rate was 22.90%(136/594). Cell screening positive rate of group A was 6.04%(846/14000), and positive coincidence rate was56.04%(348/621).The detection results of both groups had significant difference(P < 0.05). Conclusion The detection of cervical cancer of TCT was higher than Pap smear cytology, which also provides treatment direction for cancer-related diseases.%目的:探讨TCT和巴氏涂片细胞学检测在宫颈癌中临床价值。方法以我院2012年3月~2014年3月妇女保健科门诊进行宫颈癌检查的妇女为研究对象,22500例(A组)使用巴氏涂片细胞学检测,14000例(B组)使用液基细胞学检测,细胞学检测阳性的行阴道镜活检,比较分析两种方式的检测结果。结果 A组细胞筛查阳性检出率5.46%(1228/22500),阳性符合率为22.90%(136/594),B组的阳性检出率为6.04%(846/14000),阳性符合率56.04%(348/621),组间检查结果比较差异有统计学意义(P<0.05)。结论TCT对宫颈癌的检出率高于巴氏涂片细胞学检测,为宫颈癌相关疾病的治疗提供依据。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号